共 50 条
- [1] Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1356 - 1365
- [2] Dosimetric Predictors of Acute Hematologic Toxicity Due to Intensity-Modulated Pelvic Radiation Therapy with Concurrent Chemotherapy for Chinese Rectal and Cervical Cancer Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E24 - E24
- [3] Dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S277 - S278
- [6] Can Dosimetric Parameters Predict Acute Hematologic Toxicity in Rectal Cancer Patients Treated With Intensity Modulated Pelvic Radiation Therapy? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S206 - S206
- [7] Dosimetric Parameters of Acute Hematologic Toxicity in Cervical Cancer Patients Treated With Concurrent Cisplatin and Pelvic Radiation Therapy: Turkish Oncology Group Gynecological Tumor Subgroup Study INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S441 - S441
- [8] Outcomes For Cervical Cancer Patients Treated With Extended Field Intensity Modulated Radiation Therapy And Concurrent Cisplatin INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S452 - S453
- [9] Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 67 - 75
- [10] Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer Clinical and Translational Oncology, 2017, 19 : 67 - 75